IPOGrid
0001913577
Company

Semnur Pharmaceuticals, Inc.

Pharmaceutical Preparations · SMNR

follow-on priced OTC EFFECT

Filing Timeline

SEC EDGAR
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
2025-12-29 · 0001193125-25-335407
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-12-29 · 9999999995-25-003932
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-12-19 · 0001193125-25-326813
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2025-10-21 · 0001193125-25-245178
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2025-08-22 · 0001213900-25-079506
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2025-08-13 · 0001193125-25-179226
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2025-08-12 · 0001193125-25-178821
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-4/A and marks the registration effective.
2025-08-12 · 9999999995-25-002570
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2025-08-11 · 0001193125-25-177416
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2025-08-11 · 0001213900-25-073913
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2025-08-08 · 0001193125-25-177097
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2025-07-28 · 0001213900-25-068268
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2025-07-23 · 0001193125-25-163401
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2025-07-11 · 0001213900-25-063308
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2025-07-02 · 0001193125-25-154936
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2025-06-11 · 0001193125-25-139124
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2025-05-12 · 0001213900-25-041656
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2025-04-21 · 0001193125-25-087342
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2025-04-09 · 0001213900-25-030050
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2025-03-12 · 0001213900-25-022861
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2025-02-11 · 0001213900-25-012219
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2025-01-08 · 0001213900-25-002090
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-12-11 · 0001213900-24-107945
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4 in the pre-IPO sequence.
2024-11-12 · 0001213900-24-096815
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-11-06 · 0001193125-24-251843
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-10-11 · 0001213900-24-087349
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-10-07 · 0001213900-24-085926
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-09-12 · 0001213900-24-077796
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-09-05 · 0001213900-24-075738
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-08-09 · 0001213900-24-067212
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-07-10 · 0001213900-24-060539
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-12-29 · 0001213900-23-099898
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-12-29 · 0001213900-23-099912
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-11-20 · 0001213900-23-088788
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-10-11 · 0001013762-23-003255
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-31 · 0001213900-23-072485
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-30 · 0001213900-23-072291
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-28 · 0001213900-23-071033
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-04 · 0001213900-23-063196
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-04 · 0001213900-23-063216
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-07-13 · 0001213900-23-056620
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-04-12 · 0001575872-23-000550
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-04-12 · 0001575872-23-000551
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2023-01-26 · 0001575872-23-000151
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-04-07 · 0001575872-22-000253
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2022-04-06 · 0001354457-22-000223
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows CERT and registers the class of securities for exchange listing.
2022-04-06 · 0001575872-22-000249
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2022-04-06 · 9999999995-22-000844
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-04-05 · 0001575872-22-000240
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-03-28 · 0001575872-22-000218
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-03-22 · 0001575872-22-000204
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $10.00 · 7,500,000 shares · Gross proceeds $75,000,000
Class A ordinary share · Exchange Nasdaq Global Market · Ticker DECAU · Over-allotment 1,125,000 · Each unit consists of one Class A ordinary share and one-half of one redeemable warrant · Each warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share · Use of proceeds Proceeds deposited into a U.S. trust account for the initial business combination · Flags cayman_holding_company · Underwriters US Tiger Securities, Inc.
Denali Capital Acquisition Corp. is a blank check company formed to effect a merger, share exchange, asset acquisition, or similar business combination. The company is conducting an initial public offering (IPO) of 7,500,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one-half of a redeemable warrant. The offering includes a 45-day option for underwriters to purchase additional units. The company has not identified a target for its initial business combination and will not target entities headquartered in China. Proceeds will be held in a trust account, with potential liquidation if a business combination is not completed within 15 months.
2022-03-01 · 0001575872-22-000181
Comparable Deals

10 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 10 using nearest neighbors.
Showing top 8 by similarity.
+3.9%
Median day-1
50%
Above issue
-1.3%
Median week-1
-35.3%
Downside (p10)
Aardvark Therapeutics, Inc. AARD
2026-02-06 $94M Day 1: -20.9% Wk 1: -23.3%
same SICrecent IPO
Veradermics, Inc MANE
2026-02-04 - Day 1: +11.0% Wk 1: +19.0%
same SICrecent IPO
Evommune, Inc. EVMN
2025-11-06 $150M Day 1: +26.4% Wk 1: +22.0%
same SICrecent IPO
MapLight Therapeutics, Inc. MPLT
2025-10-27 $251M Day 1: +7.9% Wk 1: -0.5%
same SICrecent IPO
Agomab Therapeutics NV AGMB
2026-02-06 $200M Day 1: -8.4% Wk 1: -2.1%
same SIC grouprecent IPO
Eikon Therapeutics, Inc. EIKN
2026-02-05 $381M Day 1: -16.7% Wk 1: -19.5%
same SIC grouprecent IPO
Caring Brands, Inc. CABR
2025-11-12 - Day 1: +0.0% Wk 1: -74.5%
same SIC grouprecent IPO
Functional Brands Inc. MEHA
2025-11-05 $6M Day 1: -35.3% Wk 1: -85.4%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.